Kairos Pharma, Ltd.
KAPA
$1.20
-$0.03-2.44%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.42M | -1.26M | -980.00K | -1.05M | -253.00K |
| Total Depreciation and Amortization | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 115.00K | 39.00K |
| Total Other Non-Cash Items | 1.38M | 76.00K | -253.00K | 571.00K | -20.00K |
| Change in Net Operating Assets | -798.00K | 432.00K | -610.00K | -1.70M | 26.00K |
| Cash from Operations | -805.00K | -714.00K | -1.80M | -2.02M | -168.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 223.00K | -- | 0.00 | 40.00K | 102.00K |
| Total Debt Repaid | -- | -- | -142.00K | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 5.52M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 3.06M | 0.00 | -348.00K | 47.00K |
| Cash from Financing | 223.00K | 3.06M | -142.00K | 5.22M | 149.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -582.00K | 2.34M | -1.95M | 3.20M | -19.00K |